Novartis Investigative Site
Mons 7000
0 studies enrolling now · 5 studies all time
What they study most
Acute Heart Failure, Breast Cancer, Neoplasms, Breast, Squamous Non-small Cell Lung Cancer, Transfusional Iron Overload in β-thalassemia
Studies at this site
- ALTTO (Adjuvant Lapatinib And/Or Trastuzumab Treatment Optimisation) Study; BIG 2-06/N063D — Completed
- Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
- Phase II Study of Buparlisib + Docetaxel in Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) Patients — Stopped early
- Efficacy, Safety and Tolerability of Serelaxin When Added to Standard Therapy in AHF — Completed
- An Extension Study of Iron Chelation Therapy With Deferasirox (ICL670) in β-thalassemia Patients With Transfusional Iron Overload — Completed